本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CRISPR Therapeutics AG

52.96
+1.242.40%
盤後52.960.0020+0.00%19:52 EDT
成交量:152.51萬
成交額:8,066.88萬
市值:51.21億
市盈率:-11.13
高:53.80
開:51.33
低:51.33
收:51.72
52周最高:78.48
52周最低:44.12
股本:9,669.26萬
流通股本:9,316.62萬
量比:1.36
換手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
淨資產收益率:-26.09%
總資產收益率:-14.20%
市淨率:2.93
市盈率(LYR):-8.19

資料載入中...

2019/11/19

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/10/28

重要事件披露

Current report, items 2.02 and 9.01
2019/10/28

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/30

重要事件披露

Current report, items 1.01 and 9.01
2019/08/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/29

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/07/29

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/07/29

重要事件披露

Current report, items 2.02 and 9.01
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/28

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/26

重要事件披露

Current report, item 8.01
2019/06/19

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/13

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/13

持股變動聲明

Statement of changes in beneficial ownership of securities